Jennifer Anolik Temporarily Assumes Lead Role in Allergy, Immunology, and Rheumatology Division
Dr. Jennifer Anolik, M.D., Ph.D., has been appointed as the interim chief of the Division of Allergy, Immunology & Rheumatology (AIR) at the University of Rochester. This marks a significant milestone in Dr. Anolik's career, having spent the last 20 years as a faculty member at the university.
Dr. Anolik's journey with the University of Rochester began as a student, where she completed her M.D. and Ph.D. in biochemistry as part of the Medical Scientist Training Program. She later went on to complete her residency in internal medicine and fellowship in rheumatology at the University of Rochester Medical Center.
Throughout her career, Dr. Anolik has been continually NIH funded, a testament to her dedication and the quality of her research. She has also received research fellowships from the American Society of Hematology and the Leukemia & Lymphoma Society, and is currently involved in leading a grant application for the National Institutes of Health.
Dr. Anolik is the Principal Investigator (PI) of the Accelerating Medicines Partnership (AMP) Network, focused on developing precision medicine approaches to the treatment of autoimmune disease. She is also the program director of the Physician Scientist Training Program, offering career development to physician scientists.
In her new role, Dr. Anolik aims to break down silos with other divisions and departments and find common themes in the AIR division. Her goal is to support faculty for success, bring collaboration to clinical care and research, and prioritize education and mentorship. She hopes to encourage students, residents, and fellows to stay on as faculty, as she did.
Dr. Anolik organizes a yearly patient Lupus Education Day and has created the K Club, a program for trainees and junior faculty to present their NIH grant applications to senior faculty for input and feedback.
Dr. Anolik succeeds Christopher Ritchlin, M.D., M.P.H., who spent the last eight years as division chief. Dr. Ritchlin will remain with the University to focus on teaching and research, with a concentration on psoriatic arthritis. He was recently honored with a Lifetime Achievement Award from the National Psoriasis Foundation.
Ruth O'Regan, M.D., chair of the Department of Medicine, praised Dr. Anolik's excellence and suitability for the interim chief position. Dr. Anolik's research focuses on human B cell biology and the pathogenic mechanisms of rheumatologic conditions like rheumatoid arthritis and lupus.
As Dr. Anolik takes on her new role, she hopes to continue the growth and success of the AIR division, which under Dr. Ritchlin's tenure, grew in both size and research funding.
Read also:
- Americans Lose Insurance Under New Tax Legislation, Affecting 10 Million Citizens
- Leading Ayurvedic Practice in Bikaner, Rajasthan
- Drug therapy for ADHD effectively minimizes risks of self-harm, accidents, and criminal activities
- Pregnancy Care Providers Suggest Avoiding Marijuana and Suggest Widespread Testing for It
